Arbutus Biopharma (ABUS) Stock Forecast for 2024, 2025, 2026. Sell or Buy Prediction







A Comprehensive Guide to RoadRunner Auto Transport Services

October 22, 2024 A Comprehensive Guide to RoadRunner Auto Transport Services

If you want to ship your car from one city to another, why not hire the experts to do everything for you? They…
Mastering Trading Indicators: Your Essential Toolkit For Success

October 3, 2024 Mastering Trading Indicators: Your Essential Toolkit For Success

Often investors struggle to identify profitable trades consistently. Trading indicators provide essential data to guide trading decisions. This article explains key indicators and…
Maximizing Profits: When is the Right Time to Sell Your Business?

April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?

Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
Improve Your Financial Status: A How-To Guide

April 12, 2024 Improve Your Financial Status: A How-To Guide

Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…

Arbutus Biopharma (ABUS) Stock Forecast for 2024, 2025, 2026. Sell or Buy?

Updated: November 14, 2024 (08:54)

Sector: Healthcare

The share price of Arbutus Biopharma Corp. (ABUS) now

Latest session on the 13th of November for
Arbutus Biopharma Corp. is positive
Trading Volume: 652430
Open: 3.65 /  High: 3.755 /  Low: 3.645
What analysts predict: $5.1
52-week High/Low: $4.725 / $1.754
50-Day Moving Average: $4.024 — resistance level today
200-Day Moving Average: $3.341 — support level today

Are you interested in Arbutus Biopharma Corp. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Arbutus Biopharma stock price in 2024, 2025, 2026. How much will one Arbutus Biopharma share be worth in 2024 - 2026?

When should I take profit in Arbutus Biopharma stock? When should I record a loss on Arbutus Biopharma stock? What are analysts' forecasts for Arbutus Biopharma stock? What is the future of Arbutus Biopharma stock? We forecast Arbutus Biopharma stock performance using neural networks based on historical data on Arbutus Biopharma stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Arbutus Biopharma stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, and ) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Arbutus Biopharma shares. This happens once a day.


Historical and forecast chart of Arbutus Biopharma stock

The chart below shows the historical price of Arbutus Biopharma stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Arbutus Biopharma stock price can be found in the table below.

Long-term forecasts by years.

Arbutus Biopharma Corporation, a biopharmaceutical company, is engaged in the discovery, development and commercialization of a drug for patients with chronic hepatitis B virus (HBV) infection in the United States. Its HBV product portfolio consists of AB-836, a capsid inhibitor that can inhibit HBV replication by preventing the assembly of functional viral capsids; and AB-423, which is undergoing preclinical studies. The company is also developing RNAi preparations that use the RNA interference pathway, which allows a new approach to the treatment of diseases.

Trending Themes in the Healthcare Sector

Arbutus Biopharma daily forecast for a month

Date Target Pes. Opt. Vol., %
Nov 16 3.66 3.59 3.74 4.41
Nov 17 3.63 3.58 3.70 3.49
Nov 18 3.67 3.62 3.75 3.80
Nov 19 3.69 3.63 3.78 4.06
Nov 20 3.77 3.71 3.84 3.42
Nov 21 3.75 3.70 3.78 2.16
Nov 22 3.75 3.73 3.83 2.72
Nov 23 3.75 3.72 3.79 1.90
Nov 24 3.71 3.63 3.75 3.19
Nov 25 3.74 3.71 3.80 2.26
Nov 26 3.75 3.68 3.83 3.87
Nov 27 3.80 3.77 3.87 2.75
Nov 28 3.83 3.76 3.86 2.66
Nov 29 3.83 3.76 3.87 3.03
Nov 30 3.85 3.79 3.89 2.65
Dec 01 3.96 3.87 4.05 4.54
Dec 02 4.03 3.97 4.12 3.87
Dec 03 4.11 4.03 4.15 3.15
Dec 04 4.12 4.06 4.19 3.17
Dec 05 4.14 4.04 4.18 3.47
Dec 06 4.14 4.11 4.20 2.36
Dec 07 4.14 4.04 4.17 3.29
Dec 08 4.20 4.14 4.24 2.47
Dec 09 4.33 4.24 4.37 3.12
Dec 10 4.41 4.35 4.47 2.89
Dec 11 4.41 4.34 4.50 3.63
Dec 12 4.39 4.34 4.48 3.22
Dec 13 4.28 4.23 4.37 3.25
Dec 14 4.31 4.24 4.36 2.71
Dec 15 4.37 4.28 4.45 3.83

Arbutus Biopharma Daily Price Targets


Arbutus Biopharma Stock Forecast 11-16-2024.

Forecast target price for 11-16-2024: $3.66.
Positive dynamics for Arbutus Biopharma shares will prevail with possible volatility of 4.222%.
Pessimistic target level: 3.59
Optimistic target level: 3.74

Arbutus Biopharma Stock Forecast 11-17-2024.

Forecast target price for 11-17-2024: $3.63.
Negative dynamics for Arbutus Biopharma shares will prevail with possible volatility of 3.376%.
Pessimistic target level: 3.58
Optimistic target level: 3.70

Arbutus Biopharma Stock Forecast 11-18-2024.

Forecast target price for 11-18-2024: $3.67.
Positive dynamics for Arbutus Biopharma shares will prevail with possible volatility of 3.665%.
Pessimistic target level: 3.62
Optimistic target level: 3.75

Arbutus Biopharma Stock Forecast 11-19-2024.

Forecast target price for 11-19-2024: $3.69.
Positive dynamics for Arbutus Biopharma shares will prevail with possible volatility of 3.901%.
Pessimistic target level: 3.63
Optimistic target level: 3.78

Arbutus Biopharma Stock Forecast 11-20-2024.

Forecast target price for 11-20-2024: $3.77.
Positive dynamics for Arbutus Biopharma shares will prevail with possible volatility of 3.303%.
Pessimistic target level: 3.71
Optimistic target level: 3.84

Arbutus Biopharma Stock Forecast 11-21-2024.

Forecast target price for 11-21-2024: $3.75.
Negative dynamics for Arbutus Biopharma shares will prevail with possible volatility of 2.115%.
Pessimistic target level: 3.70
Optimistic target level: 3.78

ABUS (ABUS) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Dec. 3.66 3.39 3.80 10.81

Arbutus Biopharma forecast for this year


Arbutus Biopharma Stock Prediction for Dec 2024

An uptrend is forecast for this month with an optimal target price of $3.65638. Pessimistic: $3.39. Optimistic: $3.80



Arbutus Biopharma (ABUS) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 3.66 3.43 3.91 12.22
Feb 3.56 3.34 3.73 10.40
Mar 3.48 3.29 3.66 10.20
Apr 3.34 3.21 3.56 9.64
May 3.31 3.23 3.50 7.67
Jun 3.26 3.04 3.32 8.39
Jul 3.26 3.04 3.42 11.24
Aug 3.34 3.28 3.55 7.63
Sep 3.20 2.99 3.42 12.48
Oct 3.18 3.07 3.29 6.96
Nov 3.17 2.99 3.23 7.41
Dec 3.37 3.21 3.50 8.33

Arbutus Biopharma (ABUS) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 3.56 3.46 3.63 4.85
Feb 3.54 3.36 3.65 7.85
Mar 3.84 3.76 3.94 4.47
Apr 3.69 3.58 3.95 9.34
May 3.96 3.77 4.07 7.28
Jun 3.98 3.81 4.20 9.22
Jul 3.95 3.87 4.06 4.64
Aug 3.97 3.85 4.10 6.18
Sep 3.88 3.69 4.09 9.73
Oct 4.02 3.75 4.21 10.93
Nov 4.11 3.99 4.28 6.66
Dec 4.33 4.11 4.62 11.05

Arbutus Biopharma information and performance

Arbutus Biopharma Address

100-8900 GLENLYON PARKWAY, BURNABY, BC, CA

Market Capitalization: 689 751 000 $

Market capitalization of the Arbutus Biopharma Corp. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of ABUS shares in the company outstanding by the market price of one share.

EBITDA: -77 140 000 $

EBITDA of Arbutus Biopharma is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: None

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: None

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -0.43

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: -0.713
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 83.85

Enterprise Value (EV) /Revenue

EV To EBITDA: -5.64

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 189492000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A


Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.